Cargando…

Infliximab (IFX)-Biosimilar Induced Drug-Induced Liver Injury (DILI): A Case Report

Infliximab (IFX) is a chimeric human-murine monoclonal antibody that prevents tumor necrosis factor alpha (TNF-α) activation by binding to both soluble and transmembrane forms of TNF-α. Antagonists of TNF (anti-TNF agents) can cause drug-induced liver injury (DILI). We present a non-anti-TNF naïve p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zachou, Maria, Pikramenos, Konstantinos, Panoutsakou, Maria, Lalla, Efthimia, Androutsakos, Theodoros
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839355/ https://www.ncbi.nlm.nih.gov/pubmed/36654618 http://dx.doi.org/10.7759/cureus.32525

Ejemplares similares

Post-polypectomy coagulation syndrome: a tricky to diagnose hot snare problem that can be eliminated thanks to cold snare revolution
por: Zachou, Maria, et al.
Publicado: (2022)

Long-term Efficacy, Safety, and Immunogenicity of the Infliximab (IFX) Biosimilar, PF-06438179/GP1111, in Patients with Rheumatoid Arthritis After Switching from Reference IFX or Continuing Biosimilar Therapy: Week 54–78 Data From a Randomized, Double-Blind, Phase III Trial
por: Cohen, Stanley B., et al.
Publicado: (2020)

Infliximab-Induced Vanishing Bile Duct Syndrome
por: Eiswerth, Michael J, et al.
Publicado: (2022)

The DNA60IFX contest
por: Schatz, Michael C, et al.
Publicado: (2013)

Clinical management of patients with drug‐induced liver injury (DILI)
por: Björnsson, Einar S.
Publicado: (2021)

Genetic variations in drug-induced liver injury (DILI): resolving the puzzle
por: Stephens, Camilla, et al.
Publicado: (2012)

Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes
por: Quintás, Guillermo, et al.
Publicado: (2021)

The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment
por: Moreno-Torres, Marta, et al.
Publicado: (2022)

Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX-SIRIUS STUDY I (the IFX-SIRIUS STUDY II): Study protocol for an interventional, multicenter, open-label, single-arm clinical trial with clinical, ultrasound and biomarker assessments
por: Shimizu, Toshimasa, et al.
Publicado: (2020)

Drug-Induced Liver Injury Induced by Bioflavonoids
por: Pais, João P, et al.
Publicado: (2021)

Models of Drug Induced Liver Injury (DILI) – Current Issues and Future Perspectives
por: Kuna, Lucija, et al.
Publicado: (2018)

Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials
por: Hey-Hadavi, Juliana, et al.
Publicado: (2021)

Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues
por: Teschke, Rolf, et al.
Publicado: (2021)

Comment: Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment
por: Danjuma, Mohammed, et al.
Publicado: (2020)

Role of Hepatocyte Transporters in Drug-Induced Liver Injury (DILI)—In Vitro Testing
por: Tátrai, Péter, et al.
Publicado: (2022)

Turmeric-Associated Liver Injury: A Rare Case of Drug-Induced Liver Injury
por: Smith, David N, et al.
Publicado: (2023)

Azithromycin-Induced Liver Injury in Legionnaires' Disease
por: Wong, Krista M, et al.
Publicado: (2021)

Switching from originator infliximab to biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving clinical remission (the IFX-SIRIUS study I): Study protocol for an interventional, multicenter, open-label, single-arm and noninferiority clinical trial with clinical, ultrasound, and biomarker assessments
por: Kawashiri, Shin-ya, et al.
Publicado: (2020)

Acute Liver Injury Induced by Synthetic Cannabinoid Abuse
por: Shahbaz, Amir, et al.
Publicado: (2018)

Drug-Induced Liver Injury Caused by Amoxicillin/Clavulanate
por: Ferreira, Inês, et al.
Publicado: (2020)

Severe and Late Acute Liver Injury Induced by Capecitabine
por: Habib, Mhd Baraa, et al.
Publicado: (2021)

The rediscovery of HepG2 cells for prediction of drug induced liver injury (DILI)
por: Ghallab, Ahmed
Publicado: (2014)

Prediction and mechanistic analysis of drug-induced liver injury (DILI) based on chemical structure
por: Liu, Anika, et al.
Publicado: (2021)

Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI)
por: Brennan, Paul N, et al.
Publicado: (2021)

DILI( C ): An AI-Based Classifier to Search for Drug-Induced Liver Injury Literature
por: Rathee, Sanjay, et al.
Publicado: (2022)

Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registries
por: Bessone, Fernando, et al.
Publicado: (2022)

A Rare Case of Ibuprofen-induced Acute Liver Injury
por: Shahnazarian, Vahe, et al.
Publicado: (2018)

Voriconazole-Induced Acute Liver Injury: A Case Report
por: Pata, Ramakanth, et al.
Publicado: (2021)

Herbal Supplement-Induced Liver Injury: A Case Report
por: Khan, Haidar, et al.
Publicado: (2023)

Kratom-Induced Liver Injury: A Case Series and Clinical Implications
por: Botejue, Mahesh, et al.
Publicado: (2021)

Anabolic Steroid-Induced Cholestatic Liver Injury: A Case Report
por: Qasim Agha, Osama, et al.
Publicado: (2022)

Androgenic-Anabolic Steroids: From the Gym to Drug-Induced Liver Injury
por: Alves, Ana Sofia, et al.
Publicado: (2022)

Azithromycin-Induced Liver Injury in an Asthma Exacerbation Patient With Autoimmune Features
por: Liang, Richard, et al.
Publicado: (2022)

Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction
por: Segovia-Zafra, Antonio, et al.
Publicado: (2021)

Brain Abscesses in Crohn’s Disease as a Complication of Infliximab Therapy
por: Mansour, Mahmoud M, et al.
Publicado: (2021)

Isoniazid-Induced Acute Liver Failure Requiring Liver Transplantation
por: Almeida, Mariana S, et al.
Publicado: (2022)

Not All Herbals are Benign: A Case of Hydroxycut-induced Acute Liver Injury
por: Khetpal, Neelam, et al.
Publicado: (2020)

Cocaine and Opioid-Induced Acute Liver Injury: A Rare Case Report
por: Dolkar, Tsering, et al.
Publicado: (2022)

Tinospora cordifolia (Guduchi/Giloy)-Induced Liver Injury: A Case Review
por: Nnamani, Ikenna, et al.
Publicado: (2023)

Safety and Efficacy of Infliximab in Severe Alcoholic Hepatitis: A Systematic Review
por: Majeed, Muhammad B, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_53uknqhjn2tlmug8ggss7u8jkp